OTC:RAJAF | Free Cash Flow | TFA Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2023-12-31-$1.23M-$1.22M-$2.45M-272.40%
2022-12-31-$110,817.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$35,845.00
2024-12-31$312,006.00$349,237.00-$37,231.00
2023-12-31$359,724.00$319,487.00$40,237.005.35%
2022-12-31-$321,378.00$475.00-$321,853.00
2021-12-31-$365,363.00$100,000.00-$465,363.00